Skip to main navigation Skip to search Skip to main content

Levamisole-induced vasculopathy: A report of 2 cases and a novel histopathologic finding

  • Reza S. Jacob
  • , Claudine Yap Silva
  • , Jennifer G. Powers
  • , Stefan M. Schieke
  • , Gary Mendese
  • , Rufus W. Burlingame
  • , Daniel D. Miller
  • , Deon Wolpowitz
  • , Emmy Graber
  • , Meera Mahalingam

Research output: Contribution to journalArticlepeer-review

Abstract

Although cocaine-induced pseudovasculitis and urticarial vasculitis have been reported in the past, levamisole-induced vasculopathy with ecchymosis and necrosis, termed here LIVEN, has only recently been described in association with cocaine use. Levamisole, a veterinary antihelminthic agent used previously as an immunomodulating agent, is present as a "cutting agent" in approximately two-thirds of the cocaine currently entering the United States. Levamisole is believed to potentiate the effects of cocaine and may also be used as a "signature" for tracing its market distribution. Herein, we report 2 cases of LIVEN in patients with histories of chronic cocaine use. In both the cases, a temporal association with neutropenia preceding the eruption was noted. A novel histopathologic finding present only in the second case was the presence of extensive interstitial and perivascular neovascularization. Our 2 cases reaffirm that neutropenia may precede the cutaneous eruption of LIVEN. Case 2 extends the spectrum of histopathologic findings to include the novel phenomenon of neovascularization-hitherto unreported in this entity.

Original languageEnglish (US)
Pages (from-to)208-213
Number of pages6
JournalAmerican Journal of Dermatopathology
Volume34
Issue number2
DOIs
StatePublished - Apr 1 2012

Keywords

  • levamisole-induced vasculopathy
  • neovascularization

Fingerprint

Dive into the research topics of 'Levamisole-induced vasculopathy: A report of 2 cases and a novel histopathologic finding'. Together they form a unique fingerprint.

Cite this